New Chemo-Oil combo shows promise for liver cancer patients who Can't have surgery
NCT ID NCT07493070
First seen Mar 30, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This study tests a new, more stable mixture of chemotherapy drug and iodized oil for treating early-stage liver cancer in 30 people who cannot have surgery or choose not to. The treatment combines a procedure called TACE (which blocks the tumor's blood supply and delivers chemo) with heat-based ablation to destroy remaining cancer cells. The goal is to see if this approach can completely eliminate the tumor with fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Interventional Radiology, Fujian Medical University Union Hospital
Fuzhou, Fujian, 350001, China
Conditions
Explore the condition pages connected to this study.